To understand how ERN1 regulates the response of tumor cells to MEK inhibitors, they used CRISPR technology to generate ERN1 knockout KRAS mutant colon cancer cells and performed a genome-wide screen. The gene discussed is ERN1; the disease is malignant colon neoplasm.